Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Physicians Complain Of N.Z. Slowness In Approving Drugs

This article was originally published in PharmAsia News

Executive Summary

Diabetes experts in New Zealand complain the nation's drug-buying agency is too restrictive with its investments in drugs, causing unnecessary harm. The group said Pharmac funding for diabetes drugs and supplies has decreased in recent years even as the country faces a diabetes epidemic. The signer of a physicians' letter to Pharmac said clinicians were frustrated by the agency's lack of progress, and added it took four years to approve ace inhibitors and ARBS to protect kidneys. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC067185

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel